AI: ChronWell CEO On Why Consolidation in Healthcare Is A Good Thing

When Joe Rubinsztain started gMed, he was admittedly young—only a few years removed from medical school— and he just didn’t understand leadership that well.

“I needed to be abreast of everything and understand everything and control everything. And I needed to hire people that would do as I requested. As the company got bigger, understood that in order to grow a big company, you needed to bring in people much better than you, who knew very well what they were doing,” Rubinsztain says.

This was one of three lessons he learned in his 20 years in running gMed, a gastroenterology electronic health record company. The second was to hire people compatible with your goals as an organization. Third, respect the culture of the corporation. Rubinsztain is taking the lessons he learned at gMed, which was acquired by Modernizing Medicine in 2015, for his next act and current gig as CEO of ChronWell.

ChronWell has created an artificial intelligence-backed platform for the workers’ compensation insurance industry. The service helps a worker injured on the job by recommending self-care, on-site care or a health care facility, it follows up with the worker and manages the claim.

Chief Executive spoke to Rubinsztain about why he’s investing in artificial intelligence at ChronWell, and speaks about the trends of consumer-driven healthcare, the lack of risks taken by the insurance industry, and non-traditional consolidation between payers and providers. Below are excerpts from this conversation.

Read more at chiefexecutive.net

Image Credit:   Joe Rubinsztain, CEO of ChronWell

Thanks to Dr. ir Johannes Drooghaag. Follow him on twitter:@DrJDrooghaag

News This Week

Laboratory’s nanopore research hits a nerve

Since the discovery of biological ion channels and their role in physiology, scientists have attempted to create man-made structures that mimic their biological counterparts. New research by Lawrence Livermore National Laboratory (LLNL) scientists and [...]

Gene Therapy Promotes Nerve Regeneration

Researchers from the Netherlands Institute for Neuroscience (NIN) and the Leiden University Medical Center (LUMC) have shown that treatment using gene therapy leads to a faster recovery after nerve damage. By combining a surgical [...]

2018-08-10T15:26:39+00:00

Leave A Comment